These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 27228567)

  • 1. Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26.
    Chiu DK; Xu IM; Lai RK; Tse AP; Wei LL; Koh HY; Li LL; Lee D; Lo RC; Wong CM; Ng IO; Wong CC
    Hepatology; 2016 Sep; 64(3):797-813. PubMed ID: 27228567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL9/CCR1 induces myeloid‑derived suppressor cell recruitment to the spleen in a murine H22 orthotopic hepatoma model.
    Li B; Zhang S; Huang N; Chen H; Wang P; Yang J; Li Z
    Oncol Rep; 2019 Jan; 41(1):608-618. PubMed ID: 30365155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor-Interacting Protein Kinase 3 Deficiency Recruits Myeloid-Derived Suppressor Cells to Hepatocellular Carcinoma Through the Chemokine (C-X-C Motif) Ligand 1-Chemokine (C-X-C Motif) Receptor 2 Axis.
    Li YM; Liu ZY; Wang JC; Yu JM; Li ZC; Yang HJ; Tang J; Chen ZN
    Hepatology; 2019 Nov; 70(5):1564-1581. PubMed ID: 31021443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subsets of myeloid-derived suppressor cells in hepatocellular carcinoma express chemokines and chemokine receptors differentially.
    Zhao W; Xu Y; Xu J; Wu D; Zhao B; Yin Z; Wang X
    Int Immunopharmacol; 2015 Jun; 26(2):314-21. PubMed ID: 25891236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
    Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF
    J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma.
    Chiu DK; Tse AP; Xu IM; Di Cui J; Lai RK; Li LL; Koh HY; Tsang FH; Wei LL; Wong CM; Ng IO; Wong CC
    Nat Commun; 2017 Sep; 8(1):517. PubMed ID: 28894087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
    Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
    J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and significance of myeloid-derived suppressor cells-associated chemokine MIP-1γ and its receptor CCR1 in the spleen of hepatoma H22-bearing mice].
    Li B; Chen H; Shi M; Huang N; Kong G; Li Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Sep; 36(9):802-808. PubMed ID: 32967764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visualization and quantification of
    Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
    Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Myeloid-Derived Suppressor Cells in High-Dose-Irradiated TRAMP-C1 Tumors: A Therapeutic Target and an Index for Assessing Tumor Microenvironment.
    Fu SY; Chen FH; Wang CC; Yu CF; Chiang CS; Hong JH
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1547-1558. PubMed ID: 33188861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment.
    Chaturvedi P; Gilkes DM; Takano N; Semenza GL
    Proc Natl Acad Sci U S A; 2014 May; 111(20):E2120-9. PubMed ID: 24799675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-induced CCL28 promotes recruitment of regulatory T cells and tumor growth in liver cancer.
    Ren L; Yu Y; Wang L; Zhu Z; Lu R; Yao Z
    Oncotarget; 2016 Nov; 7(46):75763-75773. PubMed ID: 27716621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways.
    Guo X; Qiu W; Liu Q; Qian M; Wang S; Zhang Z; Gao X; Chen Z; Xue H; Li G
    Oncogene; 2018 Aug; 37(31):4239-4259. PubMed ID: 29713056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs.
    Tannenbaum CS; Rayman PA; Pavicic PG; Kim JS; Wei W; Polefko A; Wallace W; Rini BI; Morris-Stiff G; Allende DS; Hamilton T; Finke JH; Diaz-Montero CM
    Cancer Immunol Res; 2019 Oct; 7(10):1687-1699. PubMed ID: 31439615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine IL6-Mediated Activation of the STAT3-DNMT Axis Silences the TNFα-RIP1 Necroptosis Pathway to Sustain Survival and Accumulation of Myeloid-Derived Suppressor Cells.
    Smith AD; Lu C; Payne D; Paschall AV; Klement JD; Redd PS; Ibrahim ML; Yang D; Han Q; Liu Z; Shi H; Hartney TJ; Nayak-Kapoor A; Liu K
    Cancer Res; 2020 Aug; 80(15):3145-3156. PubMed ID: 32554751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic restraint stress promotes the mobilization and recruitment of myeloid-derived suppressor cells through β-adrenergic-activated CXCL5-CXCR2-Erk signaling cascades.
    Cao M; Huang W; Chen Y; Li G; Liu N; Wu Y; Wang G; Li Q; Kong D; Xue T; Yang N; Liu Y
    Int J Cancer; 2021 Jul; 149(2):460-472. PubMed ID: 33751565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated hepatic stellate cells regulate MDSC migration through the SDF-1/CXCR4 axis in an orthotopic mouse model of hepatocellular carcinoma.
    Xu Y; Fang F; Jiao H; Zheng X; Huang L; Yi X; Zhao W
    Cancer Immunol Immunother; 2019 Dec; 68(12):1959-1969. PubMed ID: 31641797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function.
    Hu CE; Gan J; Zhang RD; Cheng YR; Huang GJ
    Scand J Gastroenterol; 2011 Feb; 46(2):156-64. PubMed ID: 20822377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma.
    Liu M; Zhou J; Liu X; Feng Y; Yang W; Wu F; Cheung OK; Sun H; Zeng X; Tang W; Mok MTS; Wong J; Yeung PC; Lai PBS; Chen Z; Jin H; Chen J; Chan SL; Chan AWH; To KF; Sung JJY; Chen M; Cheng AS
    Gut; 2020 Feb; 69(2):365-379. PubMed ID: 31076403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic Stellate Cells Enhance Liver Cancer Progression by Inducing Myeloid-Derived Suppressor Cells through Interleukin-6 Signaling.
    Hsieh CC; Hung CH; Chiang M; Tsai YC; He JT
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.